Risk Factors in Cardiovascular Diseases
Abstract
Kardiyovasküler hastalık (KVH)’lar günümüzde erişkinlerde morbidite ve mortalite sebeplerinin başında gelmektedir. Bireyler KVH’lar açısından tanımlanabilirse, değiştirilebilir risk faktörlerinin düzeltilmesi ile miyokard infarktüsü (MI), inme, periferik arter hastalıkları (PAH) büyük ölçüde önlenebilmektedir. KVH’lar ortaya çıktıktan sonra morbidite ve mortalitenin artmasının yanı sıra sağlık sistemine olumsuz etkileri vardır. Bu sebeple aile hekimlerinin primer ve sekonder koruma çalışmalarına ağırlık vermesi gerekmektedir.
References
- WHO. Cardiovasculer diseases. Fact sheets. http://www.who.int/media-centre/factsheets/fs317/en/adresinden 11.05.2017 tarihinde erişilmiştir.
- WHO, Global Status Report on Noncommunicable Diseases 2014, http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf=1 adresinden 10.04.2017 tarihinde erişilmiştir.
- Diehm C, Lange S, Darius H, et al. Association of low ankle brachial index with high mortality in primary care. European Heart Journal 2006;27:1743-49.
- Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (The INTERHEART Study): Case-control study. Lancet 2004;364:937-52.
- Kumar V, Cotran RS, Robbins SL. Basic Pathology. (Türkçe çeviri eds. Tuzlalı S, Güllüoğlu M, Çevikbaş U.) 6. Baskı. Ankara, Nobel Tıp Kitabevleri Ltd. Şti., 2000:286.
- Weber C, Erl W, Weber PC. Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b. Biochem Biophys Res Commun 1995;206:621–8.
- Yamaguchi Y, Matsuno S, Kagota S, Haginaka J, Kunitomo M. Peroxynitritemediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin. Atherosclerosis 2004;172:259–65.
- Pasternak RC, Grundy TM, Levy D, Thompson PD: Task Force 3. Spectrum of risk factors for coronary heart disease. JACC 1996;27:978-90.
- Fletcher GF, Balady G, Blair SN, et al. Statement on exercise: Benefits and recommendations for physical activity. Circulation 1996;94:857-62.
- Cornelissen VA, Fagard RH. Effect of resistance training on resting blood pressure: A meta-analysis of randomized controlled trials. Journal of Hypertension 2005,23(2): 251–9.
- Lippi G, Maffulli N. Biological influence of physical exercise on hemostasis. Semin Thromb Hemost 2009;35:269–76.
- Thomas G, Haider B, Oldewurter HA, Lyons MM, Yeh CK, Regan TJ. Progression of myocardial abnormalities in experimental alcoholism. Am J Cardiol 1980;46:233-41.
- Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 2014;160:398-406.
- Bernstein AM, Sun Q, Hu FB, et al. Major dietary protein sources and risk of coronary heart disease in women. Circulation 2010;122: 876-83.
- Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999;69:30-42.
- Pietinen P, Rimm EB, Korhonen P, et al. Intake of dietary fiber and risk of coronary Heart Disease in a cohort of Finnish men. Circulation 1996;94(11):2720-7.
- World Health Organization. Obesity: Preventing and Managing the Global 3. Epidemic: Report of a WHO Consultation on Obesity. Geneva, World Health Organization Technical Report Series 894, 2000.
- Türk Hipertansiyon ve Böbrek Hastalıkları Derneği: Türk Hipertansiyon Prevalans çalışması PatenT2 (2012). http://www.turkhipertansiyon.org/prevelans_calismasi.php adresinden 11.06.2017 tarihinde erişilmiştir.
- Türkiye Endokrinoloji ve Metabolizma Derneği: Diabetes mellitus ve komplikasyonlarının tanı, tedavi ve izlem kılavuzu 2016:15. http://www.temd.org.tr/files/DIYABET_web.pdf adresinden 01.05.2017 tarihinde erişilmiştir.
- Satman İ, İmamoğlu Ş, Yılmaz C, Akalın S, Salman S. TEMD Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu. 7. Baskı. Ankara, Pelin Ofset Matbaacılık Ltd. Şti., 2015:131-2.
- Kristensen SD. The platelet-vessel wall interaction in experimental atherosclerosis and ischaemic heart disease with special reference to thrombopoiesis. Dan Med Bull 1992;39(2): 110-27.
- Endler G, Klimesch A, Sunder-Plassmann H, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br JHaematol 2002;117:399-404.
- Koloğlu S. Diabetes Mellitus. In: Koloğlu Temel ve Klinik Endokrinoloji. (ed) Erdoğan G.1. Baskı. Ankara, Medical Network ve Nobel,1996:367-86.
- Haffner SM, Letho S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Eng J Med 1998;339:229-34.
- Ginsberg HN, Goldberg IJ. Disordersof Lipoprotein Metabolism. In: Harrison’s Principles of Internal Medicine. (eds) Braun wald E, Fauci AS, Kasper DL. 15. Baskı. New York, McGraw-Hill. Vol 2, 2001;2245-57.
- Glueck CJ, Gartside PF, Fallart RW, Sielski J, Steiner PM. Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia. J Lab Clin Med 1976;88:941-57.
- Reiner Z, Carapano AL, Agewall S, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769-818.
- Grundy SM. Hypertriglyseridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998;81(4A):18-25.
- Law MR. Lowering heart disease risk with cholesterol reduction: evidence from observational studies and clinical trials. Eur Heart J Suppl 1999; suppl S: 3-8.
- Grundy SM, Wilhelmsen L, Rose G, Campbell RWF, Assmann G. Coronary heart disease in high-risk populations: lessons from Finland. Eur Heart J 1990;11:462-71.
